Search - tctmd.com

Displaying 581 - 600 of 8349

Sort: Relevancy | Date

Presentation TCT 2016

FORTITUDE: Nine-Month Clinical, Angiographic, and OCT Results With an Amorphous PLLA-Based Sirolimus-Eluting Bioresorbable Vascular Scaffold in Patients With Coronary Artery Disease

Presenter: Patrick W. Serruys, Joanna J. Wykrzykowska, Antonio Colombo

October 31, 2016

Presentation TCT 2016

YELLOW II: Relationship of Serial Change in Plaque Morphology of Obstructive Non-Culprit Lesions to HDL Efflux, Inflammation and Transcriptome Perturbations in Response to High-Dose Statin Therapy

Presenter: Spencer B. King III, Jagat Narula, Annapoorna Kini

October 31, 2016

Presentation TCT 2016

MeRes-1: Six-Month Clinical, Angiographic, IVUS, and OCT Results With a Thin-Strut PLLA-Based Sirolimus-Eluting Bioresorbable Vascular Scaffold in Patients With Coronary Artery Disease

Presenter: Patrick W. Serruys, Joanna J. Wykrzykowska, Ashok Seth

October 31, 2016

Presentation TCT 2016

TCT 30: Safety, Clinical Performance and Multi-Modality Imaging Data of the Drug Eluting Absorbable Metal Scaffold in the Treatment of Subjects with De Novo Lesions in Native Coronary Arteries at 12-Month Follow-Up-BIOSOLVE-II

Presenter: Jacques J. Koolen, Yoshinobu Onuma, Michael Haude

October 31, 2016

Presentation TCT 2016

TCT 46: Coronary Artery Aneurysms: Incididence, Etiology, Management, and Outcomes in a Long-term Follow-up

Presenter: Javier Escaned, Christoph K. Naber, Antonio Gomez Menchero

October 31, 2016

$TCT 22: Dual Mechanical Support Combining Impella Microaxial Pump and Veno-Arterial ECMO Rescues High-risk Patients in Refractory Cardiogenic Shock$

Presentation TCT 2016

TCT 22: Dual Mechanical Support Combining Impella Microaxial Pump and Veno-Arterial ECMO Rescues High-risk Patients in Refractory Cardiogenic Shock

Presenter: Tanveer Rab, Richard Smalling, Joern Tongers

October 31, 2016

Presentation TCT 2016

TCT 14: Specialist Chronic Total Occlusion (CTO) Programmes and Outcomes After CTO Percutaneous Coronary Interventions: An Observational Study of 5,496 Patients From the Pan-London CTO Cohort

Presenter: Christopher E. Buller, Sudhir Rathore, Daniel Jones

October 31, 2016

Presentation TCT 2016

TCT 10: Physiological Testing of Coronary Artery Stenosis by Computation of Invasive Coronary Angiography. The Wire-Free Functional Imaging (WIFI-II) Study

Presenter: Daniel S. Berman, Pamela S. Douglas, Jelmer Westra

October 31, 2016

Presentation TCT 2016

TCT 6: Simultaneous Impact of Thrombotic and Bleeding Risks on Use of Novel P2Y12 Inhibitors in Contemporary PCI: Results From a Large Single-Center Registry

Presenter: Dimitrios Alexopoulos, Laurent Bonello, Usman Baber

October 31, 2016

TCT 2: Worse Outcomes in Women Compared to Men After Primary PCI in STEMI Are Not Explained by Infarct Size: A Collaborative Patient-Level Pooled Analysis of 10 Randomized Trials

Presentation TCT 2016

TCT 1: Microvascular Obstruction Is Independently Associated With Adverse Events Following Primary PCI for STEMI: A Patient-Level Pooled Analysis from 7 Randomized Trials

Presenter: Andreas Baumbach, Kurt Huber, Andrea Abizaid, Jun-Jack Cheng, Rajiv Gulati, Jamil Abdalla Saad

October 31, 2016

Presentation TCT 2016

FANTOM II: Six-Month and Nine-Month Clinical and Angiographic Results With a Radiopaque Desaminotyrosine Polycarbonate-Based Sirolimus-Eluting Bioresorbable Vascular Scaffold in Patients With Coronary Artery Disease

Presenter: Patrick W. Serruys, Joanna J. Wykrzykowska, Alexandre Abizaid

October 31, 2016

News Industry News

First-In-Human Of New Polymer-Free Stent Demonstrates Favorable Angiographic And Imaging-Based Outcomes At Nine-Months

October 31, 2016

Presentation TCT 2016

B Braun - ISAR Coroflex

Presenter: Marie-Claude Morice, Christian Hengstenberg

October 31, 2016

Presentation TCT 2016

FAME I and FAME II: Predictive Value of Fractional Flow Reserve After Drug-Eluting Stent Implantation

Presenter: Spencer B. King III, Jagat Narula, Zsolt Piroth

October 31, 2016

Presentation TCT 2016

TCT 2: Worse Outcomes in Women Compared to Men After Primary PCI in STEMI Are Not Explained by Infarct Size: A Collaborative Patient-Level Pooled Analysis of 10 Randomized Trials

Presenter: Andreas Baumbach, Kurt Huber, Bjorn Redfors

October 31, 2016

Presentation TCT 2016

TCT 29: Performance and Healing Patterns After Implantation of a Novel Sirolimus-Eluting Bioresorbable Scaffold. Six-Month Follow-Up by Optical Coherence Tomography in the FANTOM II Study

Presenter: Jacques J. Koolen, Yoshinobu Onuma, Jo Simonsen

October 31, 2016

Presentation TCT 2016

TCT 29: Performance and Healing Patterns After Implantation of a Novel Sirolimus-Eluting Bioresorbable Scaffold. Six-Month Follow-Up by Optical Coherence Tomography in the FANTOM II Study

Presenter: Jacques J. Koolen, Yoshinobu Onuma, Jo Simonsen

October 31, 2016

$TCT 21: Door-to-ECMO Before Door-to-Balloon? Early Implementation of ECMO Might Improve the Survival of Patients With STEMI Complicated by Refractory Cardiogenic Shock$

Presentation TCT 2016

TCT 21: Door-to-ECMO Before Door-to-Balloon? Early Implementation of ECMO Might Improve the Survival of Patients With STEMI Complicated by Refractory Cardiogenic Shock

Presenter: Tanveer Rab, Richard Smalling, Chi-Cheng Huang

October 31, 2016

Presentation TCT 2016

TCT 13: Outcomes of Chronic Total Occlusion Percutaneous Coronary Intervention According to Dissection/Reentry vs Wire Escalation Techniques

Presenter: Christopher E. Buller, Sudhir Rathore, Lorenzo Azzalini

October 31, 2016

Presentation TCT 2016

TCT 5: Risks and Benefits of Dual Antiplatelet Therapy After Coronary Artery Bypass Graft Surgery: Insights From the ACUITY Trial

Presenter: Dimitrios Alexopoulos, Laurent Bonello, Ramin Ebrahimi

October 31, 2016

Advertisement

FORTITUDE: Nine-Month Clinical, Angiographic, and OCT Results With an Amorphous PLLA-Based Sirolimus-Eluting Bioresorbable Vascular Scaffold in Patients With Coronary Artery Disease

YELLOW II: Relationship of Serial Change in Plaque Morphology of Obstructive Non-Culprit Lesions to HDL Efflux, Inflammation and Transcriptome Perturbations in Response to High-Dose Statin Therapy

MeRes-1: Six-Month Clinical, Angiographic, IVUS, and OCT Results With a Thin-Strut PLLA-Based Sirolimus-Eluting Bioresorbable Vascular Scaffold in Patients With Coronary Artery Disease

TCT 30: Safety, Clinical Performance and Multi-Modality Imaging Data of the Drug Eluting Absorbable Metal Scaffold in the Treatment of Subjects with De Novo Lesions in Native Coronary Arteries at 12-Month Follow-Up-BIOSOLVE-II

TCT 46: Coronary Artery Aneurysms: Incididence, Etiology, Management, and Outcomes in a Long-term Follow-up

TCT 22: Dual Mechanical Support Combining Impella Microaxial Pump and Veno-Arterial ECMO Rescues High-risk Patients in Refractory Cardiogenic Shock

TCT 14: Specialist Chronic Total Occlusion (CTO) Programmes and Outcomes After CTO Percutaneous Coronary Interventions: An Observational Study of 5,496 Patients From the Pan-London CTO Cohort

TCT 10: Physiological Testing of Coronary Artery Stenosis by Computation of Invasive Coronary Angiography. The Wire-Free Functional Imaging (WIFI-II) Study

TCT 6: Simultaneous Impact of Thrombotic and Bleeding Risks on Use of Novel P2Y12 Inhibitors in Contemporary PCI: Results From a Large Single-Center Registry

TCT 1: Microvascular Obstruction Is Independently Associated With Adverse Events Following Primary PCI for STEMI: A Patient-Level Pooled Analysis from 7 Randomized Trials

FANTOM II: Six-Month and Nine-Month Clinical and Angiographic Results With a Radiopaque Desaminotyrosine Polycarbonate-Based Sirolimus-Eluting Bioresorbable Vascular Scaffold in Patients With Coronary Artery Disease

First-In-Human Of New Polymer-Free Stent Demonstrates Favorable Angiographic And Imaging-Based Outcomes At Nine-Months

B Braun - ISAR Coroflex

FAME I and FAME II: Predictive Value of Fractional Flow Reserve After Drug-Eluting Stent Implantation

TCT 2: Worse Outcomes in Women Compared to Men After Primary PCI in STEMI Are Not Explained by Infarct Size: A Collaborative Patient-Level Pooled Analysis of 10 Randomized Trials

TCT 29: Performance and Healing Patterns After Implantation of a Novel Sirolimus-Eluting Bioresorbable Scaffold. Six-Month Follow-Up by Optical Coherence Tomography in the FANTOM II Study

TCT 29: Performance and Healing Patterns After Implantation of a Novel Sirolimus-Eluting Bioresorbable Scaffold. Six-Month Follow-Up by Optical Coherence Tomography in the FANTOM II Study

TCT 21: Door-to-ECMO Before Door-to-Balloon? Early Implementation of ECMO Might Improve the Survival of Patients With STEMI Complicated by Refractory Cardiogenic Shock

TCT 13: Outcomes of Chronic Total Occlusion Percutaneous Coronary Intervention According to Dissection/Reentry vs Wire Escalation Techniques

TCT 5: Risks and Benefits of Dual Antiplatelet Therapy After Coronary Artery Bypass Graft Surgery: Insights From the ACUITY Trial

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content